VLXVX | VSVNX | VLXVX / VSVNX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 7 years | 2 years | - |
Gain YTD | 15.793 | 15.738 | 100% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.8B | 1.07B | 827% |
Annual Yield % from dividends | 1.93 | 1.47 | 131% |
Returns for 1 year | 21.77 | 22.17 | 98% |
Returns for 3 years | 9.34 | N/A | - |
Returns for 5 years | 49.81 | N/A | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GLFOX | 15.89 | 0.14 | +0.89% |
Lazard Global Listed Infrastructure Open | |||
WFEFX | 12.52 | 0.07 | +0.56% |
Allspring International Equity C | |||
FDLSX | 22.24 | -0.10 | -0.45% |
Fidelity Select Leisure | |||
LQFLX | 13.71 | -0.10 | -0.72% |
Lord Abbett Focused Large Cap Value R3 | |||
FBTCX | 24.58 | -0.53 | -2.11% |
Fidelity Advisor Biotechnology C |